PTSD and depression care without drugs: Missouri myths checked

Living with PTSD, or loving someone who does, means hearing a lot of confident claims about treatment, from well-meaning friends, online forums, and clinics with something to sell. This piece checks several of them, with Missourians in mind who are wary of ketamine and want to understand the options that involve no medication.

We lean on a summer survey we commissioned, whose 443 respondents live in a band of ten Midwest states, plus what is publicly known about the treatments. The figures are final, and nothing here is medical advice.

Why this matters to so many people

Respondents described plenty of unfinished business with standard care. Seventy-two percent said standard medication had not helped their own, or a loved one's, depression, anxiety, or PTSD. When we asked what they would type into a search engine to find help, answers included "ptsd help," "help with ptsd," and "ptsd treatments," plain requests for relief.

Many respondents also had close ties to service: 29 percent said a veteran or first responder was their child or other relative, and 6 percent said their spouse or partner.

Myth: "TMS is approved for PTSD."

Not as of this writing. TMS, or transcranial magnetic stimulation, is FDA cleared for major depression in adults whom antidepressants have not helped, and for certain other conditions, but PTSD is not among its cleared uses. Researchers are studying it for PTSD, and a clinician might discuss it if depression is also present, but know which condition a treatment is actually cleared for.

That precision matters to people. Among respondents, 59 percent rated FDA approval as deciding or weighing heavily on whether to try something new.

Myth: "Ketamine is approved for PTSD."

Also untrue. Esketamine, sold as Spravato, holds its FDA approval in treatment-resistant depression, not PTSD, and must be administered under supervision at a certified healthcare site; Brain Recovery Centers spells out what Spravato is approved to treat and how it is given. IV ketamine for depression or PTSD is off label, and home ketamine products are a separate, looser category. Some clinics blur these lines, so if ketamine makes you wary, hold firm and ask exactly what is offered and for which diagnosis.

Myth: "If you don't want pills, there's nothing else for PTSD."

The reverse is closer to true. Major clinical guidelines, including those used in military health care, treat several trauma-focused psychotherapies as first-line care for PTSD:

• Prolonged exposure therapy, which helps a person approach avoided memories and situations gradually and safely.
• Cognitive processing therapy, which works on the beliefs and self-blame that often follow trauma.
• EMDR, eye movement desensitization and reprocessing, which pairs recalling traumatic memories with guided eye movements or other bilateral stimulation.

None of these use medication, and like TMS, many people have never heard them named. In our survey, 64 percent of respondents valued a drug-free choice while TMS was a known quantity to just 25 percent, so the drug-free landscape is bigger than most realize.

Myth: "Therapy for PTSD is just talking about your feelings."

Not these therapies. Trauma-focused treatment is structured, time-limited, and built on specific skills and exercises. It can be demanding, often with homework between sessions and facing things you would rather avoid. It is not open-ended venting, and a qualified therapist should tell you which approach they use and why.

Myth: "Trauma therapy is only for people who served."

Not so. Prolonged exposure and cognitive processing therapy have been studied in civilians as well as service members and are used for PTSD after assaults, crashes, disasters, and the kinds of calls first responders take. A spouse or parent who never served can ask about them as readily as a veteran. Ask your doctor for a referral, or ask a therapist which trauma-focused approach they are trained in.

Among respondents, 5 percent said TRICARE was part of their coverage. If that is your family, ask the plan how it handles referrals for trauma-focused therapy and for TMS, since its steps may differ from a civilian plan's.

Myth: "Being skeptical means you're in denial."

Doubt is not denial. Offered the phrase ketamine therapy and asked for an initial reaction, 21 percent of respondents landed on skeptical and 9 percent on negative; cautious but open was the top answer at 34 percent. Wanting to understand something before agreeing is reasonable, especially after trauma, when trust is hard to rebuild. The point is that doubt about one treatment should not become a reason to skip care altogether.

Myth: "You should stop your meds if you want a drug-free approach."

Please do not do this alone. Stopping an antidepressant or other psychiatric medication suddenly can cause withdrawal and a return of symptoms. Many people begin trauma-focused therapy while still on medication and adjust later with their prescriber.

What to do next in Missouri

• Ask your doctor directly about trauma-focused therapy, and about TMS if depression is also involved. A physician's advice would most sway 74 percent of our respondents toward trying something new.
• Check coverage. For 85 percent of respondents, the insurance question was one of their two biggest, and MO HealthNet, Medicare, TRICARE, and commercial plans each have their own rules.
• Consider telehealth. Trauma-focused therapy often works by video, a help in rural parts of the state.
• Bring support. A family member can help with scheduling, paperwork, and follow-through.

A qualified clinician is the one to judge whether a given treatment suits you or your loved one.

Anyone with thoughts of suicide can call or text 988, and veterans can press 1. Someone answers at any hour.

Methodology

Commissioned and paid for by the publisher, the survey ran on Pollfish's consumer panel and stopped taking responses June 23, 2026. It includes 443 completes, each from a consenting adult between the ages of 18 and 64 somewhere in the ten-state Midwest sample. Multi-select questions report shares of all respondents, and the figures are final.